Core Viewpoint - The Snowflake Inc. class action lawsuit alleges that the company and certain former executives made misleading statements regarding product efficiency and revenue forecasts, leading to significant stock price declines [3][4]. Group 1: Class Action Details - The class action lawsuit is titled Patel v. Snowflake Inc., and it involves purchasers of Snowflake Class A common stock from June 27, 2023, to February 28, 2024, with a deadline of April 27, 2026, to seek lead plaintiff status [1]. - The lawsuit claims that Snowflake's product efficiency gains, Iceberg Tables, and tiered storage pricing were expected to negatively impact consumption and revenues, casting doubt on the company's ability to reach $10 billion in revenue by 2029 [3]. Group 2: Financial Impact - On February 28, 2024, Snowflake announced financial results indicating increased revenue headwinds due to product efficiency gains and other factors, resulting in an over 18% drop in the stock price [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Snowflake Class A common stock during the class period to seek lead plaintiff status, which involves directing the class action lawsuit on behalf of all members [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone, marking its fourth 1 ranking in the past five years [6].

Core Viewpoint - Driven Brands Holdings Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with significant financial misstatements impacting its stock value [1][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Clark v. Driven Brands Holdings Inc., and it includes purchasers of Driven Brands common stock from May 9, 2023, to February 24, 2026 [1]. - Investors have until May 8, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Driven Brands and certain executives made false or misleading statements and failed to disclose critical financial errors [3]. Group 2: Allegations of Financial Misstatements - Allegations include errors in lease recording affecting right of use assets and liabilities as of December 28, 2024, and September 27, 2025 [3]. - There were inaccuracies in reporting cash balances and operating cash flows, leading to overstatements of cash and revenue for fiscal years 2023 and 2024 [3]. - Misclassification of supply and other expenses as company-operated store expenses was also noted for fiscal years 2023 and 2024 [3]. - Additional errors were identified related to income tax provisions, revenue recognition, and other financial misclassifications [3]. Group 3: Impact of Financial Disclosure - On February 25, 2026, Driven Brands disclosed material errors in its previously issued financial statements for fiscal years 2023 and 2024, stating that these statements should not be relied upon [4]. - Following this disclosure, Driven Brands' stock price fell nearly 40% [4]. Group 4: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Driven Brands common stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff represents the interests of all class members and can select a law firm for litigation [5]. Group 5: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 [6]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years [6].

Core Insights - Theravance Biopharma, Inc. is under investigation for potential violations of federal securities laws following a significant stock drop after the failure of the CYPRESS trial [1][3]. Financial Performance - In Q3 2025, the company projected near-term milestones totaling $75 million for the fourth quarter, with $50 million expected from Trelegy and $25 million from YUPELRI [2]. - The CFO reaffirmed all elements of the 2025 financial guidance during the Q2 2025 earnings call, without addressing potential impacts from the CYPRESS trial failure [2]. Recent Developments - On March 3, 2026, Theravance announced that the CYPRESS trial did not meet its primary endpoint, leading to an accelerated strategic review and the termination of the ampreloxetine program [3]. - Following this announcement, the company's stock experienced a decline of approximately 26% in a single trading session [3].

Core Viewpoint - A class action lawsuit has been filed against Beyond Meat, Inc. on behalf of investors who acquired its securities during the specified Class Period, alleging misleading statements regarding the company's financial health and operations [1][4]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC, representing investors who purchased Beyond Meat securities from February 27, 2025, to November 11, 2025 [1][2]. - Investors have until March 24, 2026, to seek appointment as lead plaintiff representative of the class [2]. Group 2: Company Performance and Statements - Throughout the Class Period, Beyond Meat claimed it was focused on achieving EBITDA-positive operations by the end of 2026, emphasizing cost reductions and operational optimization while downplaying revenue growth [3]. - The complaint alleges that Beyond Meat's statements were materially false and misleading, as the company failed to disclose impairments of long-lived assets and the likelihood of a significant non-cash impairment charge [4]. Group 3: Stock Impact and Financial Disclosures - On October 24, 2025, Beyond Meat announced it expected to record a material impairment charge, leading to a stock price drop of over 23% in one trading day [4]. - Subsequent disclosures in November 2025 regarding delayed SEC filings and $77.4 million in impairment charges resulted in further stock declines of approximately 16%, 9%, and 9%, causing substantial losses for investors [4].

YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF†) are investigating the proposed sale of ON24, Inc. (NYSE: ONTF) to Cvent. Under the terms of the proposed transaction, shareholders of ON24 will receive $8.10 in cash for each share of ON24 that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration underv...Back to Newsroom ...

Core Viewpoint - PayPal Holdings, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential during the specified class period from February 25, 2025, to February 2, 2026 [1] Summary by Relevant Sections Class Action Details - The lawsuit, titled Darcy v. PayPal Holdings, Inc., claims that PayPal and its executives violated the Securities Exchange Act of 1934 [1] - Investors who acquired PayPal common stock during the class period have until April 20, 2026, to seek appointment as lead plaintiff [1] Allegations Against PayPal - The complaint alleges that PayPal created a false impression of having reliable information about its projected revenue and growth while downplaying risks from seasonality and macroeconomic factors [1] - PayPal's growth initiatives, particularly in Branded Checkout, were deemed unrealistic and unattainable under the leadership of CEO James Alexander Chriss [1] - On February 3, 2026, PayPal reported disappointing earnings for Q4 and full fiscal year 2025, withdrawing its 2027 financial targets, which led to a stock price drop of over 20% [1] Financial and Operational Context - The lawsuit cites macroeconomic challenges, competition, and operational issues as contributing factors to PayPal's poor performance [1] - The transition of CEO James Alexander Chriss was also highlighted as a significant event impacting investor confidence [1] Legal Process for Lead Plaintiff - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal stock during the class period to seek lead plaintiff status [1] - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [1]

Core Viewpoint - NuScale Power Corporation is facing a class action lawsuit due to alleged misleading statements regarding its commercialization partnership with ENTRA1 Energy LLC and significant financial losses reported in its recent fiscal quarter [1] Group 1: Class Action Lawsuit Details - The class action lawsuit is filed by Robbins Geller Rudman & Dowd LLP for investors who purchased NuScale Class A common stock between May 13, 2025, and November 6, 2025 [1] - The lawsuit alleges violations of the Securities Exchange Act of 1934 by NuScale, its executives, and Fluor Corporation [1] - Investors have until April 20, 2026, to seek appointment as lead plaintiff in the lawsuit [1] Group 2: Allegations Against NuScale - The lawsuit claims that NuScale made false statements about ENTRA1's capabilities, stating that ENTRA1 had never built or operated significant projects in nuclear power generation [1] - It is alleged that NuScale's reliance on ENTRA1 exposed its commercialization strategy to undisclosed risks, including potential delays and regulatory challenges [1] - The lawsuit highlights that NuScale's general and administrative expenses surged over 3,000% to $519 million in the third fiscal quarter, primarily due to a $495 million payment to ENTRA1 [1] Group 3: Financial Impact - Following the disclosure of financial losses, NuScale's quarterly net loss increased to $532 million from $46 million in the prior year [1] - The company's stock price fell more than 12% over a two-day trading period after the announcement of these financial results [1] - The agreement with TVA could lead to milestone payments to ENTRA1 exceeding $3 billion, raising further concerns about NuScale's financial commitments [1]

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into potential securities fraud involving Encompass Health Corporation and may file a class action on behalf of investors [1]. Group 1: Investigation and Legal Actions - The Portnoy Law Firm is encouraging investors to contact them to discuss their legal rights and options for pursuing claims to recover losses [2]. - The firm offers a complimentary case evaluation for investors affected by the alleged corporate wrongdoing [2]. Group 2: Stock Performance and Allegations - Encompass Health's stock price dropped by $12.39, or 10.4%, closing at $107.28 per share on July 15, 2025, following allegations of poor performance on safety measures in for-profit hospitals [3]. - A New York Times article reported that Encompass's hospitals had "alarming mistakes" leading to patient fatalities and highlighted that 34 facilities had significantly worse rates of potentially preventable readmissions according to Medicare [3].

Core Viewpoint - Eos Energy Enterprises, Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with significant financial losses reported by investors during the class period from November 5, 2025, to February 26, 2026 [1] Group 1: Class Action Lawsuit Details - The class action lawsuit, Yung v. Eos Energy Enterprises, Inc., allows investors who suffered substantial losses to seek appointment as lead plaintiff by May 5, 2026 [1] - Allegations include that Eos Energy made false or misleading statements regarding its production capabilities and financial guidance [1] - The lawsuit claims that Eos Energy's revenue for full year 2025 was $114.2 million, significantly below the guidance of $150 million to $160 million [1] Group 2: Financial Performance - Eos Energy reported a gross loss of $143.8 million and a net loss attributable to shareholders of $969.6 million for the year 2025 [1] - The adjusted EBITDA loss was reported at $219.1 million, with a capacity milestone reached five weeks later than planned [1] - Following the announcement of these results, Eos Energy's stock price fell by more than 39% [1] Group 3: Company Background - Eos Energy designs, manufactures, and markets zinc-based battery energy storage systems for utility-scale commercial and industrial applications [1] - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized for its significant recoveries in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [1]

Core Viewpoint - Driven Brands is facing a class action lawsuit for securities fraud due to significant accounting errors and internal control failures, resulting in a nearly 40% drop in stock price [1][1][1] Company Overview - Driven Brands Holdings Inc. operates in the automotive aftermarket services sector, managing vehicle maintenance, repair, collision, glass, and car wash brands [1][1][1] Financial Impact - The company's stock fell from $16.61 per share on February 24, 2026, to $9.99 per share on February 25, 2026, marking a decline of approximately 39.8% [1][1][1] - The financial restatements will affect fiscal years 2023 and 2024, along with quarterly and year-to-date financials for 2025 [1][1][1] Allegations and Misconduct - The lawsuit alleges that Driven Brands issued materially false financial statements and failed to maintain effective internal controls, leading to pervasive accounting errors, including lease accounting issues and improperly recognized revenue from 2023 to 2025 [1][1][1] - The company had previously assured investors of the accuracy of its financial reporting and the effectiveness of its internal controls [1][1][1] Legal Proceedings - The class action lawsuit is filed in the U.S. District Court for the Southern District of New York, with a lead plaintiff deadline set for May 8, 2026 [1][1][1] - Investors are encouraged to seek legal representation to discuss their rights regarding the case [1][1][1]